CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage
Author
A Majeed
CS Brown
+25Â more
CT January
DM Witt
GF Tomaselli
GYH Lip
HA Wilsey
JA Frontera
JC Hemphill 3rd
KA Parsels
KC Siontis
M Sheikh-Taha
ME Barra
MJ Korobey
MM Horvath
MN Smith
PA Harris
Panos NG Cook AM, John S, Jones GM, Neurocritical Care Society Pharmacy Study G
R Grandhi
R Sarode
Schulman S Gross PL, Ritchie B, Nahirniak S, Lin Y, Lieberman L, Carrier M, Crowther MA, Ghosh I, Lazo-Langner A, Zondag M, Study I
SE Culbreth
SJ Connolly
SJ Connolly
TA Allison
TR Reynolds
VM Stevens
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref